• Your shopping cart is empty!

  • CLSI I/LA30-A

CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute, 02/01/2008

Publisher: CLSI

File Format: PDF

$108.00$216.21


Published:01/02/2008

Pages:44

Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI M100-S20 Erratum

CLSI M100-S20 Erratum

Erratum to Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, M100S20

$109.00 $218.77

CLSI EP30-A (R2018)

CLSI EP30-A (R2018)

Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine; Approved Guideline, EP30AE

$90.00 $180.00

CLSI POCT09-A (R2018)

CLSI POCT09-A (R2018)

Selection Criteria for Point-of-Care Testing Devices; Approved Guideline, POCT09A

$90.00 $180.00

CLSI H59-P

CLSI H59-P

Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Proposed Guideline, H59PE

$100.00 $201.84